Nicolas A.F. Chronos

Author

Also Known As

NICOLAS A. F. CHRONOS, NICOLAS A.F. CHRONOS, Nicolas A Chronos, Nicolas A F Chronos, Nicolas A. Chronos, Nicolas A. F. Chronos, Nicolas A.F Chronos, Nicolas A.F. Chronos, Nicolas AF Chronos

Publications

4.3K

Citations

H-Index

Concepts

All Affiliations

Emory University Saint Joseph’s Translational Research Institute Stanford University The Royal Free Hospital University College London

About

Nicolas A.F. Chronos is an author at Emory University specializing in medicine, cardiovascular disease, and vascular biology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	13	15	2K
2	Biomedical Engineering	9	9	1.5K
3	Engineering	7	7	1.2K
4	Health Sciences	2	2	82
5	Cell Biology	1	1	67

Nicolas A.F. Chronos

Publications

3.4K

Citations

H-Index

Page 1

	Year	Citations
Human tissue-engineered blood vessels for adult arterial revascularization Nicolas L’Heureux, Nathalie Dusserre, Gerhardt König, Nature Medicine Regenerative MedicineTissue EngineeringAdult Arterial RevascularizationVascular GraftsVascular Tissue Engineering	2006	1.1K
Pharmacological Treatment of Coronary Artery Disease With Recombinant Fibroblast Growth Factor-2 Michael Simons, Brian H. Annex, Roger J. Laham, Circulation	2002	647
The effect of blockade of the CD11/CD18 integrin receptor on infarct size in patients with acute myocardial infarction treated with direct angioplasty: the results of the HALT-MI study David P. Faxon, Raymond J. Gibbons, Nicolas A.F. Chronos, Journal of the American College of Cardiology ThrombosisHalt-mi StudyCardiovascular DiseaseMyocardial InfarctionVascular Biology	2002	284
Extracellular Matrix Scaffold for Cardiac Repair Keith A. Robinson, Jinshen Li, Megumi Mathison, Circulation	2005	232
Drug-Eluting Stents in Preclinical Studies Robert S. Schwartz, Elazer R. Edelman, Renu Virmani, Circulation Cardiovascular Interventions Percutaneous Coronary InterventionTranslational MedicinePreclinical Drug EvaluationCardiovascular DiseaseMedicine	2008	217
Scanning electron microscopic analysis of defects in polymer coatings of three commercially available stents: comparison of BiodivYsio, Taxus and Cypher stents. Yoritaka Otsuka, Nicolas A.F. Chronos, Robert P. Apkarian, PubMed	2007	112
Reduced Thrombus Formation by Hyaluronic Acid Coating of Endovascular Devices Stefan Verheye, Christos P. Markou, Mahomed Y. Salame, Arteriosclerosis Thrombosis and Vascular Biology	2000	112
Aspirin Does Not Affect the Flow Cytometric Detection of Fibrinogen Binding to, or Release of α-Granules or Lysosomes from, Human Platelets Nicolas A.F. Chronos, Darren Wilson, Sarah L. Janes, Clinical Science	1994	98
Recommendations for Successful Training on Methods of Delivery of Biologics for Cardiac Regeneration Nabil Dib, Philippe Menasché, Jozef Bartúnek, JACC: Cardiovascular Interventions Tissue EngineeringRegenerative MedicineEngineeringSuccessful TrainingCardiac Regeneration	2010	78
Endothelium-Dependent Vasomotor Dysfunction in Pig Coronary Arteries With Paclitaxel-Eluting Stents Is Associated With Inflammation and Oxidative Stress Lakshmana Pendyala, Jinsheng Li, Toshiro Shinke, JACC: Cardiovascular Interventions InflammationPercutaneous Coronary InterventionVascular DiseaseCardiovascular DiseasePaclitaxel-eluting Stents	2009	69

Page 1